PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
RCUS vs. STNE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between RCUS and STNE is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

RCUS vs. STNE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Arcus Biosciences, Inc. (RCUS) and StoneCo Ltd. (STNE). The values are adjusted to include any dividend payments, if applicable.

-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-39.29%
-26.60%
RCUS
STNE

Key characteristics

Sharpe Ratio

RCUS:

-0.60

STNE:

-0.89

Sortino Ratio

RCUS:

-0.65

STNE:

-1.21

Omega Ratio

RCUS:

0.93

STNE:

0.86

Calmar Ratio

RCUS:

-0.46

STNE:

-0.42

Martin Ratio

RCUS:

-1.61

STNE:

-1.17

Ulcer Index

RCUS:

22.37%

STNE:

33.12%

Daily Std Dev

RCUS:

60.42%

STNE:

43.50%

Max Drawdown

RCUS:

-77.84%

STNE:

-92.31%

Current Drawdown

RCUS:

-77.84%

STNE:

-89.23%

Fundamentals

Market Cap

RCUS:

$1.02B

STNE:

$2.99B

EPS

RCUS:

-$3.19

STNE:

$1.12

Total Revenue (TTM)

RCUS:

$232.00M

STNE:

$9.39B

Gross Profit (TTM)

RCUS:

$227.00M

STNE:

$6.85B

EBITDA (TTM)

RCUS:

-$160.00M

STNE:

$3.47B

Returns By Period

In the year-to-date period, RCUS achieves a -27.87% return, which is significantly lower than STNE's 27.10% return.


RCUS

YTD

-27.87%

1M

-24.05%

6M

-39.29%

1Y

-34.55%

5Y*

-9.14%

10Y*

N/A

STNE

YTD

27.10%

1M

20.02%

6M

-26.59%

1Y

-37.58%

5Y*

-25.34%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

RCUS vs. STNE — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RCUS
The Risk-Adjusted Performance Rank of RCUS is 1515
Overall Rank
The Sharpe Ratio Rank of RCUS is 1616
Sharpe Ratio Rank
The Sortino Ratio Rank of RCUS is 1717
Sortino Ratio Rank
The Omega Ratio Rank of RCUS is 1919
Omega Ratio Rank
The Calmar Ratio Rank of RCUS is 1919
Calmar Ratio Rank
The Martin Ratio Rank of RCUS is 33
Martin Ratio Rank

STNE
The Risk-Adjusted Performance Rank of STNE is 1212
Overall Rank
The Sharpe Ratio Rank of STNE is 66
Sharpe Ratio Rank
The Sortino Ratio Rank of STNE is 88
Sortino Ratio Rank
The Omega Ratio Rank of STNE is 1010
Omega Ratio Rank
The Calmar Ratio Rank of STNE is 2121
Calmar Ratio Rank
The Martin Ratio Rank of STNE is 1717
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

RCUS vs. STNE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Arcus Biosciences, Inc. (RCUS) and StoneCo Ltd. (STNE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for RCUS, currently valued at -0.60, compared to the broader market-2.000.002.00-0.60-0.89
The chart of Sortino ratio for RCUS, currently valued at -0.65, compared to the broader market-4.00-2.000.002.004.006.00-0.65-1.21
The chart of Omega ratio for RCUS, currently valued at 0.93, compared to the broader market0.501.001.502.000.930.86
The chart of Calmar ratio for RCUS, currently valued at -0.46, compared to the broader market0.002.004.006.00-0.46-0.42
The chart of Martin ratio for RCUS, currently valued at -1.61, compared to the broader market-10.000.0010.0020.0030.00-1.61-1.17
RCUS
STNE

The current RCUS Sharpe Ratio is -0.60, which is higher than the STNE Sharpe Ratio of -0.89. The chart below compares the historical Sharpe Ratios of RCUS and STNE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.50SeptemberOctoberNovemberDecember2025February
-0.60
-0.89
RCUS
STNE

Dividends

RCUS vs. STNE - Dividend Comparison

Neither RCUS nor STNE has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

RCUS vs. STNE - Drawdown Comparison

The maximum RCUS drawdown since its inception was -77.84%, smaller than the maximum STNE drawdown of -92.31%. Use the drawdown chart below to compare losses from any high point for RCUS and STNE. For additional features, visit the drawdowns tool.


-95.00%-90.00%-85.00%-80.00%-75.00%-70.00%-65.00%-60.00%SeptemberOctoberNovemberDecember2025February
-77.84%
-89.23%
RCUS
STNE

Volatility

RCUS vs. STNE - Volatility Comparison

Arcus Biosciences, Inc. (RCUS) has a higher volatility of 21.94% compared to StoneCo Ltd. (STNE) at 12.86%. This indicates that RCUS's price experiences larger fluctuations and is considered to be riskier than STNE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%SeptemberOctoberNovemberDecember2025February
21.94%
12.86%
RCUS
STNE

Financials

RCUS vs. STNE - Financials Comparison

This section allows you to compare key financial metrics between Arcus Biosciences, Inc. and StoneCo Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab